Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roemer

Showing results (141-150 of 165) with videos related to

Pageof 17
Sort By:
Blood|December 17, 2020
Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphomaG Tjitske Los-de Vries, Mintsje de Boer, Erik van Dijk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2016
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict OutcomeMargaretha G M Roemer, Ranjana H Advani, Azra H Ligon, et al.
The Journal of Molecular Diagnostics : JMD|August 28, 2021
PCR-Free Shallow Whole Genome Sequencing for Chromosomal Copy Number Detection from Plasma of Cancer Patients Is an Efficient Alternative to the Conventional PCR-Based ApproachJamie J Beagan, Esther E E Drees, Phylicia Stathi, et al.
Cell Genomics|February 13, 2023
A multi-platform reference for somatic structural variation detectionJose Espejo Valle-Inclan, Nicolle J M Besselink, Ewart de Bruijn, et al.
The Lancet. Oncology|July 25, 2016
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trialAnas Younes, Armando Santoro, Margaret Shipp, et al.
JAMA Oncology|February 26, 2016
Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and VulvaBrooke E Howitt, Heather H Sun, Margaretha G M Roemer, et al.
Hemasphere|July 11, 2022
Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 TreatmentEsther E E Drees, Yvonne W S Jauw, Erik van Dijk, et al.
Blood Advances|January 8, 2024
Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOSA Vera de Jonge, Carolien Duetz, Wassilis S C Bruins, et al.
The Journal of Molecular Diagnostics : JMD|May 8, 2021
Clinical Validation of Whole Genome Sequencing for Cancer DiagnosticsPaul Roepman, Ewart de Bruijn, Stef van Lieshout, et al.
Haematologica|July 4, 2024
Response to DA-EPOCH-R is associated with activation of 'fitter' cytotoxic T cells in patients with newly diagnosed double and triple hit high-grade B-cell lymphomaA Vera De Jonge, Wassilis S C Bruins, Carolien Duetz, et al.
Pageof 17

Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
Blood|December 17, 2020
Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphomaG Tjitske Los-de Vries, Mintsje de Boer, Erik van Dijk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2016
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict OutcomeMargaretha G M Roemer, Ranjana H Advani, Azra H Ligon, et al.
The Journal of Molecular Diagnostics : JMD|August 28, 2021
PCR-Free Shallow Whole Genome Sequencing for Chromosomal Copy Number Detection from Plasma of Cancer Patients Is an Efficient Alternative to the Conventional PCR-Based ApproachJamie J Beagan, Esther E E Drees, Phylicia Stathi, et al.
Cell Genomics|February 13, 2023
A multi-platform reference for somatic structural variation detectionJose Espejo Valle-Inclan, Nicolle J M Besselink, Ewart de Bruijn, et al.
The Lancet. Oncology|July 25, 2016
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trialAnas Younes, Armando Santoro, Margaret Shipp, et al.
JAMA Oncology|February 26, 2016
Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and VulvaBrooke E Howitt, Heather H Sun, Margaretha G M Roemer, et al.
Hemasphere|July 11, 2022
Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 TreatmentEsther E E Drees, Yvonne W S Jauw, Erik van Dijk, et al.
Blood Advances|January 8, 2024
Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOSA Vera de Jonge, Carolien Duetz, Wassilis S C Bruins, et al.
The Journal of Molecular Diagnostics : JMD|May 8, 2021
Clinical Validation of Whole Genome Sequencing for Cancer DiagnosticsPaul Roepman, Ewart de Bruijn, Stef van Lieshout, et al.
Haematologica|July 4, 2024
Response to DA-EPOCH-R is associated with activation of 'fitter' cytotoxic T cells in patients with newly diagnosed double and triple hit high-grade B-cell lymphomaA Vera De Jonge, Wassilis S C Bruins, Carolien Duetz, et al.
Pageof 17